Slit2 expression was also down-regulated in grade III–IV glioma tissues, and the viability, migration and tube formation of ECs were significantly reduced in the Robo4 overexpression group that was pretreated with exogenous Slit2. The gene discussed is ROBO4; the disease is glioma.